Diabetes drug tested to boost cancer treatment
NCT ID NCT05487859
Summary
This study aimed to see if adding the diabetes medication acarbose to standard immunotherapy is safe and tolerable for people with advanced kidney cancer that has spread. Researchers wanted to check if this combination could help control the cancer better and see how it affects the bacteria in the gut. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.